Cargando…
GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
BACKGROUND: TNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factor...
Autores principales: | Xie, Huaying, Yan, Tingting, Lu, Xinxin, Du, Yueyao, Xu, Shuguang, Kong, Yu, Yu, Liangjie, Sun, Jian, Zhou, Liheng, Ma, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585280/ https://www.ncbi.nlm.nih.gov/pubmed/36275705 http://dx.doi.org/10.3389/fimmu.2022.1033367 |
Ejemplares similares
-
Identification and characterization of GLDC as host susceptibility gene to severe influenza
por: Zhou, Jie, et al.
Publicado: (2018) -
gldc Is Essential for Renal Progenitor Patterning during Kidney Development
por: Weaver, Nicole E., et al.
Publicado: (2022) -
Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
por: Jäger, Katharina, et al.
Publicado: (2019) -
miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2
por: Zhao, Mingchuan, et al.
Publicado: (2020) -
Novel GLDC Compound Heterozygous Variant Leading to Nonketotic Hyperglycinemia: Case Report and Literature Review
por: Cao, Yanyan, et al.
Publicado: (2021)